Caesars Entertainment Launches NBA Triple Double Power Combo on Its Online Casino Platforms With the 2025 NBA Playoffs in Full Swing
NBA Triple Double Power Combo is now live for the 2025 NBA Playoffs exclusively across Caesars Palace Online Casino, Horseshoe Online Casino, and Caesars Sportsbook & Casino in New Jersey, Michigan, Pennsylvania and Ontario.
'With the NBA Playoffs in full swing, NBA Triple Double Power Combo is the ultimate destination for basketball enthusiasts on our online gaming platforms,' said Matt Sunderland, Senior Vice President and Chief iGaming Officer at Caesars Digital. 'Whether you're a die-hard fan or just love the thrill of the game, this exciting new title offers can't-miss gameplay inspired by the intense action on the NBA hardwood during Playoff season.'
NBA Triple Double Power Combo draws inspiration from the NBA's unmatched Playoff energy. Set against the backdrop of a vibrant basketball court with fans cheering from the stands, this game seamlessly integrates the thrill of a classic slot interface with dynamic basketball-themed visuals made for any fan of the sport.
'We're thrilled to see NBA Triple Double Power Combo go live with Caesars Entertainment, especially as excitement builds during the 2025 NBA Playoffs,' said Joann Pierce, Chief Commercial Officer at Games Global. 'This launch marks a major milestone in our U.S. growth journey, pairing a high-energy, basketball-themed slot experience with one of the most iconic names in entertainment. It's another powerful example of Games Global's commitment to delivering standout, market-relevant content across regulated states.'
Caesars Palace Online Casino, Horseshoe Online Casino, and Caesars Sportsbook & Casino are available on iOS, Android, and desktop for those 21 and older in New Jersey, Pennsylvania, Michigan, Ontario, and West Virginia. Each platform offers a dynamic online casino experience with a range of unique Caesars-branded games alongside hundreds of classic land-based casino favorites and core casino game mechanics, including high limit slots, private live dealer tables, linked progressive jackpots, variations of poker and roulette, and more.
Caesars Entertainment is an industry leader in Responsible Gaming, known for pioneering Responsible Gaming awareness and education. In 1989, Caesars became the first commercial casino company to address problem gambling by launching the industry's first Responsible Gaming program, Project 21. Today, the Company's commitment to ensuring all players are aware of Responsible Gaming resources remains steadfast and spans all of Caesars' digital platforms and world-class destinations in which it operates. Caesars Entertainment proudly enforces an enhanced 21+ gaming policy that prevents individuals under the age of 21 from using Caesars Rewards and restricts access to its gaming products for individuals under the age of 21.
In March 2024, Caesars Sportsbook received the prestigious RG Check accreditation from the Responsible Gambling Council in Ontario, Canada, which recognizes companies that achieve the highest standards for their Responsible Gaming practices. Just a few months later, the Company was awarded the National Council on Problem Gambling's award for Corporate Social Responsibility. For more information about Caesars Entertainment's Responsible Gaming program, please visit https://www.caesars.com/corporate.
About Caesars Entertainment, Inc.
Caesars Entertainment, Inc. (NASDAQ: CZR) is the largest casino-entertainment Company in the U.S. and one of the world's most diversified casino-entertainment providers. Since its beginning in Reno, NV, in 1937, Caesars Entertainment, Inc. has grown through development of new resorts, expansions and acquisitions. Caesars Entertainment, Inc.'s resorts operate primarily under the Caesars ®, Harrah's ®, Horseshoe ®, and Eldorado ® brand names. Caesars Entertainment, Inc. offers diversified gaming, entertainment and hospitality amenities, one-of-a-kind destinations, and a full suite of mobile and online gaming and sports betting experiences. All tied to its industry-leading Caesars Rewards loyalty program, the Company focuses on building value with its guests through a unique combination of impeccable service, operational excellence and technology leadership. Caesars is committed to its employees, suppliers, communities and the environment through its PEOPLE PLANET PLAY framework. Know When To Stop Before You Start. ® Gambling Problem? Call or text 1-800-GAMBLER. For more information, please visit www.caesars.com/corporate.
About Games Global
Games Global is a leading developer, distributor and marketer of innovative online, casino-style gaming ('iGaming') content and integrated business-to-business solutions to iGaming operators in regulated markets globally. Games Global has one of the largest networks of exclusive iGaming content studios, and its 42 in-house and partnered studios have developed more than 1,400 proprietary games over the past 20 years. With a market leading offering including slot games, table games, video poker, video bingo, progressive jackpots, game show games, crash games and live casino games, Games Global is a key content provider to iGaming operators, supporting the rapid growth of iGaming in regulated markets.
Know When To Stop Before You Start ®. Gambling Problem? MI, NJ, WV, PA (Affiliated with Harrah's Philadelphia): If you or someone you know has a gambling problem, crisis counseling and referral services can be accessed by calling 1-800-GAMBLER (1-800-426-2537) or WV: Visit 1800gambler.net; ON: Visit connexontario.ca or call 1-866-531-2600 or text CONNEX to 247247. Accruing Caesars Rewards credits is currently not available in Ontario when using Caesars Sportsbook & Casino, Caesars Palace Online Casino, and Horseshoe Online Casino. ©2025, Caesars Entertainment
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
Qifu Technology, Inc. (QFIN) to Rebrand as Qfin Holdings
We recently compiled a list of Qifu Technology, Inc. (NASDAQ: QFIN) stands fifth on our list and is currently undergoing a rebranding process. Qifu Technology, Inc. (NASDAQ:QFIN), a leading AI-powered Credit-Tech platform in China, is undergoing a major transformation. The company recently announced it will rebrand as Qfin Holdings, Inc., following shareholder approval in June 2025, marking a strategic shift alongside new leadership appointments and updated governance policies. Recognized as a 'Most Honored Company' in the 2025 Extel Asia Best Managed Teams rankings, the business has earned top accolades for its CEO, CFO, and investor relations team, reflecting its excellence in corporate transparency and execution. Qifu Technology, Inc. (NASDAQ:QFIN) is doubling down on its 'AI + Finance' strategy, with innovations aimed at revolutionizing digital lending and risk assessment. A major highlight is TRIDENT, its proprietary Multimodal Large Language Model (MLLM), designed to enhance fraud detection, streamline customer service, and optimize user experience using multimodal data. A lab technician inspecting a credit card processor chip. The corporation is also expanding through embedded finance channels, with nearly half of the new users in Q1 2025 acquired via APIs. At the same time, it continues to scale its capital-light business model, providing more efficient and lower-risk loan facilitation. With ongoing investment in AI research and partnerships with academic institutions, Qifu Technology, Inc. (NASDAQ:QFIN) is cementing its position as a pioneer in China's evolving fintech landscape. While we acknowledge the potential of QFIN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Sign in to access your portfolio
Yahoo
20 minutes ago
- Yahoo
2 Top Dividend Stocks to Buy Right Now and Hold Forever
Key Points Amgen can replenish its lineup thanks to a deep pipeline. AbbVie has a knack for getting around headwinds. Both drugmakers have strong dividend track records. 10 stocks we like better than Amgen › Over the long run, dividends can make a significant difference in your returns, whether you choose to reinvest the payouts or retain the cash for other purposes. However, many companies that offer dividends aren't exactly attractive to hold on to for a long time. Some have somewhat shaky underlying operations, and others are not inclined to regularly raise their dividends. Thankfully, some income stocks on the market don't have these issues, and their shares are worth holding on to forever. Let's consider two examples: Amgen (NASDAQ: AMGN) and AbbVie (NYSE: ABBV). 1. Amgen If you're an income-seeking investor, Amgen has several qualities that you'll appreciate. First, it's a leader in healthcare, a defensive industry. The demand for the medicines that the company develops -- some of which are lifesaving -- won't stop even during economic downturns, nor will physicians stop prescribing them. Amgen is well equipped to perform regardless of economic conditions. The drugmaker generates consistent revenue and earnings. Second, it continues to innovate. True, it has encountered clinical setbacks of late; its investigational weight management medicine, MariTide, didn't perform as well in mid-stage studies as expected. However, the company recently reported phase 3 results for bemarituzumab, a medicine it's developing for gastric cancer, the fifth leading cause of cancer death worldwide. This product now appears likely to secure regulatory approval and make a meaningful contribution to Amgen's results for a while. The company will continue to face competition and patent cliffs, but it's been able to perform well over the long run despite these challenges, thanks to its innovative abilities. Amgen can also rely on licensing deals and acquisitions to bolster its lineup and pipeline. In 2023, it acquired Horizon Therapeutics and its medicine for thyroid eye disease, Tepezza, for about $28 billion. Amgen has been able to push Tepezza's reach far beyond what the smaller Horizon would have been able to accomplish; it earned approval for the medicines in countries like Japan and Brazil, while pouring money into advertising and marketing efforts. Third, Amgen has a strong track record of dividend payments. The biotech initiated a payout in 2011, and since then, it's increased its dividends every single year. It currently offers a forward yield of 3.1%, considerably higher than the S&P 500's average of 1.3%. And the cash payout ratio of 46.5% appears reasonable, leaving ample room for further payout increases. Amgen's ability to develop novel lifesaving medicines, its consistent financial results, and its regular payout increases make it a top dividend stock to buy and hold for the long term. 2. AbbVie Although AbbVie has lagged behind the market over the past three years, this period highlights the company's resilient qualities. After losing patent exclusivity in January 2023 for Humira, an immunology medicine that was its best-selling drug and also the most lucrative in the industry's history, management predicted that the company would return to top-line growth in 2025. AbbVie resumed revenue growth last year, ahead of schedule. It's not rare for drugmakers to go through several years of declining revenue following a major patent cliff, nor is it necessarily a cause for concern. AbbVie's ability to bounce back as quickly as it did speaks volumes about the strength of its underlying business, its ability to navigate competition -- biosimilar and otherwise -- and its long-term prospects. True, the company encountered a significant setback when a seemingly promising candidate for schizophrenia called emraclidine, which it had gotten its hands on through an acquisition, failed mid-stage studies. AbbVie has faced similar problems before and has bounced back. The company had bet on a cancer medicine called Rova-T to be a significant growth driver post-Keytruda. However, this medicine failed in the clinic. Instead, AbbVie is now relying on Skyrizi and Rinvoq, two immunosuppressants, to drive top-line growth. These medicines have surpassed its own expectations, and they should continue to be significant contributors for years to come. The company has consistently found ways to overcome setbacks and challenges. Its financial results remain robust; the pipeline is deep; the balance sheet is strong. And its dividend track record is outstanding: AbbVie is a Dividend King, boasting 53 consecutive years of payout increases. Its forward yield now tops 3.4%, while the cash payout ratio of 61.8% is still reasonable. This is another dividend stock that you could safely include in a long-term portfolio. Should you invest $1,000 in Amgen right now? Before you buy stock in Amgen, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Amgen wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $636,628!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,063,471!* Now, it's worth noting Stock Advisor's total average return is 1,041% — a market-crushing outperformance compared to 183% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 28, 2025 Prosper Junior Bakiny has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends AbbVie and Amgen. The Motley Fool has a disclosure policy. 2 Top Dividend Stocks to Buy Right Now and Hold Forever was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
20 minutes ago
- Yahoo
Wells Fargo Raises PT on Enphase Energy, Inc. (ENPH) from $42 to $45
Enphase Energy, Inc. (NASDAQ:ENPH) is included in our list of the . An assembly line of lithium-ion batteries for energy storage solutions with workers in the background. While the second-quarter performance of Enphase Energy, Inc. (NASDAQ:ENPH) showed steady growth, the company's forward-looking momentum gained analysts' attention. The company reported financial results for Q2 2025 on July 22, 2025. The company continued its growth in energy resilience and smart home integration with $363.2 million in revenue, 1.53 million microinverters shipped, and record IQ Battery volumes in the second quarter. Although Q2 guidance remains soft, Wells Fargo, on July 24, 2025, increased its price target on ENPH from $42 to $45, citing improved clarity for 2026 and long-term growth potential. Digging deeper into the company's Q2 performance, Enphase Energy, Inc. (NASDAQ:ENPH) expanded its global footprint. Its IQ EV chargers reached more European markets, and balcony solar kits were launched in Belgium and Germany. Furthermore, by securing tax incentives under the Inflation Reduction Act, the company progressed well with its U.S. manufacturing. With 2026 expected to be a critical year for the company, it is included in our list of cheap lithium stocks. Enphase Energy, Inc. (NASDAQ:ENPH) is a global energy technology company, supplying microinverter-based solar and battery systems. It is included in our list of cheap lithium stocks. While we acknowledge the potential of ENPH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 14 Cheap Transportation Stocks to Buy According to Analysts and 10 Cheap Lithium Stocks to Buy According to Hedge Funds. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
